Premium
Treatment selection for base of tongue carcinoma
Author(s) -
Hintz Brace L.,
Robert Kagan A.,
Wollin Myron,
Rao Aroor R.,
Ryoo Monica C.,
Nussbaum Herman,
Rowland John
Publication year - 1989
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.2930410307
Subject(s) - medicine , tongue , tongue neoplasm , radiation therapy , basal cell , surgery , carcinoma , cancer , nuclear medicine , pathology
Sixty‐two previously untreated patients with squamous cell carcinoma of the base of tongue were retrospectively analyzed. The American Joint Committee on Cancer (AJCC) Stage distribution was I‐3, II‐7, III‐24, and IV‐28. The choice of treatment was nonrandomized. The local control was 10/18 with high‐dose preoperative radiation, 17/30 with external beam radiation only, and 4/14 with external beam plus interstitial implantation. The median survival for the three treatment regimens were 63, 51, and 13 months, respectively. Preoperative radiation is suggested for tumors with inferior (laryngeal) spread or those with extensive superior extension (to tonsillar fossa and beyond). For centrally placed lesions in the base of the tongue (with or without lateral hypopharyngeal wall spread), radiation alone is recommended. An interstitial implantation should be restricted to lesions equal to or less than 4 × 3 × 2.5 cm 3 . Since this insertion is technically more demanding than for tumors of the mobile tongue, they should be performed by the more experienced brachytherapist.